Stocks and Investing Stocks and Investing
Wed, May 15, 2024

Liisa Bayko Maintained (AKRO) at Buy with Decreased Target to $38 on, May 15th, 2024


Published on 2024-10-28 11:23:47 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of Evercore ISI Group, Maintained "Akero Therapeutics, Inc." (AKRO) at Buy with Decreased Target from $50 to $38 on, May 15th, 2024.

Liisa has made no other calls on AKRO in the last 4 months.



There are 4 other peers that have a rating on AKRO. Out of the 4 peers that are also analyzing AKRO, 1 agrees with Liisa's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alexandria Hammond of "B of A Securities" Initiated at Hold and Held Target at $30 on, Monday, April 22nd, 2024


These are the ratings of the 3 analyists that currently disagree with Liisa


  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Monday, May 13th, 2024
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $56 on, Monday, May 13th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, March 5th, 2024
Contributing Sources